Вы находитесь на странице: 1из 16

France use entry mode

1. Exporting
Exporting is the process of selling of goods and services produced in one country to
other countries.

There are two types of exporting:

A) Direct exports represent the most basic mode of exporting made by a


(holding) company, capitalizing on economies of scale in production
concentrated in the home country and affording better control over
distribution. Direct export works the best if the volumesare small. Large
volumes of export may trigger protectionism. The main characteristic of direct
exports entry model is that there are no intermediaries.
Types
Sales representatives
Sales representatives silas represent foreign suppliers/manufacturers in their local
markets for an established commission on sales. Provide support services to a
manufacturer regarding local advertising, local sales presentations, customs
clearance formalities, legal requirements. Manufacturers of highly technical services
or products such as production machinery, benefit the most from sales
representation.
Importing distributors
Importing distributors purchase product in their own right and resell it in their local
markets to wholesalers, retailers, or both. Importing distributors are a good market
entry strategy for products that are carried in inventory, such as toys, appliances,
prepared food.

B) indirect exporting.
Indirect exports is the process of exporting through domestically based export
intermediaries. The exporter has no control over its products in the foreign
market.

1.Export trading companies (ETCs)


These provide support services of the entire export process for one or more
suppliers. Attractive to suppliers that are not familiar with exporting as ETCs usually
perform all the necessary work: locate overseas trading partners, present the
product, quote on specific enquiries, etc.

2 Export management companies (EMCs)


These are similar to ETCs in the way that they usually export for producers. Unlike
ETCs, they rarely take on export credit risks and carry one type of product, not
representing competing ones. Usually, EMCs trade on behalf of their suppliers as
their export departments.

3 Export merchants
Export merchants are wholesale companies that buy unpackaged products from
suppliers/manufacturers for resale overseas under their own brand names. The
advantage of export merchants is promotion. One of the disadvantages for using
export merchants result in presence of identical products under different brand
names and pricing on the market, meaning that export merchants activities may
hinder manufacturers exporting efforts.

4 Confirming houses
These are intermediate sellers that work for foreign buyers. They receive the product
requirements from their clients, negotiate purchases, make delivery, and pay the
suppliers/manufacturers. An opportunity here arises in the fact that if the client likes

the product it may become a trade representative. A potential disadvantage includes


suppliers unawareness and lack of control over what a confirming house does with
their product.
5 Nonconforming purchasing agents
These are similar to confirming houses with the exception that they do not pay the
suppliers directly payments take place between a supplier/manufacturer and a
foreign buyer.

2) Licensing
An international licensing agreement allows foreign firms, either exclusively or nonexclusively to manufacture a proprietors product for a fixed term in a specific market.
Summarizing, in this foreign market entry mode, a licensor in the home country
makes limited rights or resources available to the licensee in the host country. The
rights or resources may include patents, trademarks, managerial skills, technology,
and others that can make it possible for the licensee to manufacture and sell in the
host country a similar product to the one the licensor has already been producing
and selling in the home country without requiring the licensor to open a new
operation overseas. The licensor earnings usually take forms of one time payments,
technical fees and royalty payments usually calculated as a percentage of sales.

3) Franchising
The by the franchisor. In addition to that, while a licensing agreement involves things
such as intellectual property, trade secrets and others while in franchising it is limited
to trademarks and operating know-how of the business.

Required document
Check if health care industry need a permit or certificate
Requirements for a permit or certificate will depend on:

the type of product

your products commodity code

where your product originated from

whether youre exporting or importing

your products final destination

Using classification to find licences


When they

import, identify the commodity code for their goods to find out if you

need a licence.
They can also use the Tariff to check if need a permit.

check your products code in the Tariff, and look up the rules associated with it

check the rules regarding the origin of healthcare products - see the guide on
the rules of origin

check the rules that vary according to whether they are importing or exporting
the product, and its final destination.

Declarations and licences


Using a Single Administrative Document (SAD), most exports to outside the EU must
be declared to HMRC through the Customs Handling of Import and Export Freight
(CHIEF) system. They can do this electronically using the National Export System
(NES). See the guide on the UKs import and export processing system CHIEF.

However, the SAD is an export declaration, not a licence to export goods. If your
goods need a licence you must obtain one separately before the goods are due to
leave the UK or EU.

Major import licences, permits and certificate


They need a licence if you are importing or exporting certain Common Agricultural
Policy
(CAP) commodities from or to a country not in the EU. Licences help to monitor and
control these markets. These are issued by the Rural Payments Agency (RPA) - you
can read guidance on CAP licences.
Licences for importing and exporting particular healthcare products
Apart from the licences supplied by the main government departments, they may
need many other licences to trade internationally in a wide range of products.
If healthcare business includes trade in certain services they must make sure
specific information is available about how you work to your customers before you
complete contracts or make agreements.
From 2013 onwards, special rules will also apply to firms supplying communications
services. Find guidance on the Provision of Services Regulations 2009.
Importing and exporting of medicines and medical devices is regulated by the
Medicines and Healthcare Products Regulatory Agency (MHRA). Find out about
licensing medicines and medical devices on the MHRA websiteor see Healthcare
and medical: international trade regulations.
Under Registration, Evaluation, and Authorisation of Chemicals (REACH) legislation,
importers or manufacturers of more than one tonne of chemicals a year must register
with the European Chemicals Agency and declare any dangerous chemicals placed
on the market.
Strict rules apply to trading in biotechnology products. Biotechnologists, for example,
must comply with export control regulations co- ordinated by BIS, particularly for

materials which can be used in the manufacture of chemical warfare. For more
information, see the guide on biotechnology and pharmaceuticals.
Worldwide trade in rough diamonds is controlled by the Kimberley Process.
Traders must register with Defra or the Forestry Commission prior to importation of
any plant, forestry or timber product, including wooden packing materials. For
controlled forestry or timber imports an advanced notification to the Forestry
Commission is required.
.
EXPORT DOCUMENTS
Commercial Invoice
A commercial invoice is a bill for the goods from the seller to the buyer. These
invoices are often used by governments to determine the true value of goods when
assessing customs duties. Governments that use the commercial invoice to control
imports will often specify its form, content, number of copies, language to be used,
and other characteristics.
Export Packing List
Considerably more detailed and informative than a standard domestic packing list,
an export packing list lists seller, buyer, shipper, invoice number, date of shipment,
mode of transport, carrier, and itemizes quantity, description, the type of package,
such as a box, crate, drum, or carton, the quantity of packages, total net and gross
weight (in kilograms), package marks, and dimensions, if appropriate. Both
commercial stationers and freight forwarders carry packing list forms. A packing list
may serve as conforming document. It is not a substitute for a commercial invoice. In
addition, U.S. and foreign customs officials may use the export packing list to check
the cargo.
Pro Forma Invoice
A pro forma invoice is an invoice prepared by the exporter before shipping the
goods, informing the buyer of the goods to be sent, their value, and other key
specifications. It also can be used as an offering of sale or price quotation.

TRANSPORTATION DOCUMENTS
Airway Bill
Air freight shipments require airway bills. Airway bills are shipper-specific (i.e.,
USPS, Fed-Ex, UPS, DHL, etc.).
Bill of Lading
A bill of lading is a contract between the owner of the goods and the carrier (as with
domestic shipments). For vessels, there are two types: a straight bill of lading, which
is non-negotiable, and a negotiable or shipper's order bill of lading. The latter can be
bought, sold, or traded while the goods are in transit. The customer usually needs an
original as proof of ownership to take possession of the goods.

EXPORT COMPLIANCE DOCUMENTS


Export Licenses
An export license is a government document that authorizes the export of specific
goods in specific quantities to a particular destination. This document may be
required for most or all exports to some countries or for other countries only under
special circumstances. Examples of export license certificates include those issued
by the Department of Commerces Bureau of Industry and Security (dual use
articles), the State Departments Directorate of Defense Trade Controls (defense
articles), the Nuclear Regulatory Commission (nuclear materials), and the U.S. Drug
Enforcement Administration (controlled substances and precursor chemicals).
Destination Control Statement
A Destination Control Statement (DCS) is required for exports from the United States
for items on the Commerce Control List that are outside of EAR99 (products for
which no license is required) or controlled under the International Traffic in Arms
Regulations (ITAR). A DCS appears on the commercial invoice, ocean bill of lading,
or airway bill to notify the carrier and all foreign parties that the item can be exported
only to certain destinations.

CERTIFICATES OF ORGIN
Generic Certificate of Origin
The Certificate of Origin (CO) is required by some countries for all or only certain
products. In many cases, a statement of origin printed on company letterhead will
suffice. The exporter should verify whether a CO is required with the buyer and/or an
experienced shipper/freight forwarder or the Trade Information Center.
OTHER CERTIFICATES FOR SHIPMENTS OF SPECIFIC GOODS
Certificate of Analysis:
A certificate of analysis can be required for seeds, grain, health foods, dietary
supplements, fruits and vegetables, and pharmaceutical products.
Certificate of Free Sale
Certificate of free sale may be issued for biologics, food, drugs, medical devices and
veterinary medicine. More information is available from the Food and Drug
Administration. Health authorities in some states as well as some trade associations
also issue Certificates of Free Sale.
Dangerous Goods Certificate
Exports submitted for handling by air carriers and air freight forwarders classified as
dangerous goods need to be accompanied by the Shippers Declaration for
Dangerous Goods required by the International Air Transport Association (IATA). The
exporter is responsible for accuracy of the form and ensuring that requirements
related to packaging, marking, and other required information by IATA have been
met.
For shipment of dangerous goods it is critical to identify goods by proper name,
comply with packaging and labeling requirements, which vary depending upon the
type of product shipper and the country shipped toFor ocean exports, hazardous
material regulations are contained in the International Maritime Dangerous Goods
regulations.
Fisheries Certificate
The National Marine Fisheries Service conducts inspections and analyses of fishery

commodities for export.


Inspection Certificate
Weight and Quality certificates should be provided in accordance with governing
USDA/GIPSA regulations for loading at port and loading at source/mill site as
appropriate. A certificate of origin certified by the local chamber of commerce at the
load port and a phytosanitary certificate issued by APHIS/USDA and fumigation
certificate are to be provided to the buyer. Costs of all inspection, as well as
certificates/documents at the load port, are usually the responsibility of the seller.
Independent inspection certificates may required in some instances.
Pre-Shipment Inspections
The governments of a number of countries have contracted with international
inspection companies to verify the quantity, quality, and price of shipments imported
into their countries. The purpose of such inspections is to ensure that the price
charged by the exporter reflects the true value of the goods, to prevent substandard
goods from entering the country, and to deflect attempts to avoid payment of
customs duties..
Insurance Certificate
Insurance certificates are used to assure the consignee that insurance will cover the
loss of or damage to the cargo during transit. These can be obtained from your
freight forwarder or publishing house.

Balance sheet

Balance Sheet of Cadila


Healthcare

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves

------------------- in Rs. Cr. ------------------Mar '14

Mar '13

Mar '12

Mar '11

12 mths

12 mths

12 mths

12 mths

102.40
102.40
0.00
0.00
3,527.50

102.40
102.40
0.00
0.00
2,809.10

102.40
102.40
0.00
0.00
2,454.70

102.40
102.40
0.00
0.00
1,987.50

Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

3,629.90
888.40
522.80
1,411.20
5,041.10
Mar '14

2,911.50
1,052.50
593.00
1,645.50
4,557.00
Mar '13

2,557.10
749.20
346.60
1,095.80
3,652.90
Mar '12

2,089.90
531.70
32.30
564.00
2,653.90
Mar '11

12 mths

12 mths

12 mths

12 mths

Application Of Funds
Gross Block
Less: Revaluation Reserves
Less: Accum. Depreciation
Net Block
Capital Work in Progress
Investments
Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deferred Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets
Miscellaneous Expenses
Total Assets

2,288.90
0.00
724.80
1,564.10
530.60
1,557.70
663.50
722.00
89.40
1,474.90
1,115.80
0.00
2,590.70
0.00
904.50
297.50
1,202.00
1,388.70
0.00
5,041.10

2,125.50
0.00
628.40
1,497.10
463.80
1,279.90
587.20
683.00
91.60
1,361.80
947.40
0.00
2,309.20
0.00
781.00
212.00
993.00
1,316.20
0.00
4,557.00

2,016.20
0.00
798.50
1,217.70
334.70
1,212.20
501.20
581.20
118.30
1,200.70
799.60
0.00
2,000.30
0.00
884.90
227.10
1,112.00
888.30
0.00
3,652.90

1,732.50
0.00
695.90
1,036.60
233.70
698.80
464.50
475.10
14.10
953.70
537.20
28.30
1,519.20
0.00
654.00
180.40
834.40
684.80
0.00
2,653.90

Contingent Liabilities
Book Value (Rs)

1,242.20
177.29

1,238.10
142.20

361.70
124.89

122.40
102.07

Profit & Loss account of


Cadila Healthcare

Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Admin Expenses
Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

Operating Profit
PBDIT
Interest
PBDT
Depreciation
Other Written Off
Profit Before Tax
Extra-ordinary items
PBT (Post Extra-ord Items)
Tax
Reported Net Profit
Total Value Addition
Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)
Shares in issue (lakhs)
Earning Per Share (Rs)
Equity Dividend (%)
Book Value (Rs)

------------------- in Rs. Cr. ------------------Mar '14

Mar '13

Mar '12

Mar '11

12 mths

12 mths

12 mths

12 mths

12

4,042.10
0.00
4,042.10
308.60
35.70
4,386.40

3,675.70
0.00
3,675.70
52.90
9.00
3,737.60

3,194.00
41.80
3,152.20
169.20
57.10
3,378.50

2,213.70
34.60
2,179.10
806.90
34.60
3,020.60

1,9

1,539.50
113.30
525.10
0.00
0.00
1,092.90
0.00
3,270.80
Mar '14

1,347.70
116.50
522.50
0.00
0.00
991.70
0.00
2,978.40
Mar '13

1,157.80
94.00
455.00
49.10
762.20
12.70
0.00
2,530.80
Mar '12

934.80
71.90
371.10
48.70
746.10
74.40
0.00
2,247.00
Mar '11

1,7
M

12 mths

12 mths

12 mths

12 mths

12

807.00
1,115.60
42.50
1,073.10
127.40
0.00
945.70
0.00
945.70
42.10
903.60
1,731.30
0.00
184.30
27.30

706.30
759.20
111.00
648.20
116.80
0.00
531.40
0.00
531.40
32.80
498.60
1,630.70
0.00
153.60
19.80

678.50
847.70
69.10
778.60
108.20
0.00
670.40
0.00
670.40
12.90
657.50
1,373.00
0.00
153.60
17.00

-33.30
773.60
39.50
734.10
96.90
0.00
637.20
10.60
647.80
37.40
610.40
1,312.20
0.00
128.00
14.60

1
6

2,047.49
44.13
180.00
177.29

2,047.49
24.35
150.00
142.20

2,047.49
32.11
150.00
124.89

2,047.49
29.81
125.00
102.07

1,3

1,8
5

2,4

5
9

1
1

Balance Sheet of Cipla

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves
Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

Application Of Funds
Gross Block
Less: Revaluation Reserves
Less: Accum. Depreciation
Net Block
Capital Work in Progress
Investments
Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deferred Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets
Miscellaneous Expenses
Total Assets

------------------- in Rs. Cr. ------------------Mar '14


Mar '13
Mar '12
Mar '11

12 mths

12 mths

12 mths

12 mths

12

160.58
160.58
0.00
0.00
9,931.06
10,091.64
0.00
877.34
877.34
10,968.98
Mar '14

160.58
160.58
0.00
0.00
8,708.94
8,869.52
9.49
956.32
965.81
9,835.33
Mar '13

160.58
160.58
0.00
0.00
7,389.70
7,550.28
10.00
2.20
12.20
7,562.48
Mar '12

160.58
160.58
0.00
0.00
6,452.37
6,612.95
2.95
437.53
440.48
7,053.43
Mar '11

1
1

12 mths

12 mths

12 mths

12 mths

12

5,394.36
0.00
1,870.17
3,524.19
376.69
3,587.13
2,511.16
1,728.10
46.04
4,285.30
1,150.69
0.00
5,435.99
0.00
1,636.96
318.06
1,955.02
3,480.97
0.00
10,968.98

4,983.81
0.00
1,565.52
3,418.29
350.34
2,601.82
2,343.37
1,645.22
105.07
4,093.66
1,029.10
0.00
5,122.76
0.00
1,380.91
276.97
1,657.88
3,464.88
0.00
9,835.33

4,298.18
0.00
1,295.52
3,002.66
343.45
1,035.15
1,824.50
1,519.31
55.06
3,398.87
1,213.66
0.00
4,612.53
0.00
1,190.78
240.53
1,431.31
3,181.22
0.00
7,562.48

3,928.47
0.00
1,060.82
2,867.65
253.07
570.65
1,883.16
1,497.04
83.98
3,464.18
1,292.28
0.00
4,756.46
0.00
1,174.52
219.88
1,394.40
3,362.06
0.00
7,053.43

2,8

5,7
5,9

5,9
M

8
2,0
6
2
1,5
1,5

3,1
2,3

5,4

1,1
1,3
2,5
2,9

5,9

Contingent Liabilities
Book Value (Rs)

1,201.36
125.69

Profit & Loss account of Cipla

------------------- in Rs. Cr. ------------------Mar '14


Mar '13
Mar '12
Mar '11

12 mths

12 mths

12 mths

12 mths

12

9,380.29
0.00
9,380.29
280.28
158.12
9,818.69

8,202.42
0.00
8,202.42
229.13
290.75
8,722.30

6,977.50
0.00
6,977.50
148.30
-11.24
7,114.56

6,331.09
0.00
6,331.09
91.64
138.71
6,561.44

5,6

4,002.79
191.84
1,284.75
0.00
0.00
2,069.50
0.00
7,548.88
Mar '14

3,440.15
211.17
969.28
0.00
0.00
1,753.43
0.00
6,374.03
Mar '13

2,947.97
211.32
728.21
0.00
0.00
1,496.90
0.00
5,384.40
Mar '12

3,136.29
183.65
540.33
0.00
0.00
1,288.83
0.00
5,149.10
Mar '11

2,6

12 mths

12 mths

12 mths

12 mths

12

1,989.53
2,269.81
127.86
2,141.95
323.61
0.00

2,119.14
2,348.27
33.38
2,314.89
303.03
0.00

1,581.86
1,730.16
26.63
1,703.53
282.07
0.00

1,320.70
1,412.34
12.92
1,399.42
248.03
0.00

1,3
1,5

Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Admin Expenses
Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

Operating Profit
PBDIT
Interest
PBDT
Depreciation
Other Written Off

3,993.66
110.47

1,320.07
94.04

1,110.96
82.36

5,6
1
1
5,9

3
2
8
1

4,4
M

1,4
1

Profit Before Tax


Extra-ordinary items
PBT (Post Extra-ord Items)
Tax
Reported Net Profit
Total Value Addition
Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)
Shares in issue (lakhs)
Earning Per Share (Rs)
Equity Dividend (%)
Book Value (Rs)

Balance Sheet of Zydus


Wellness

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves
Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

Application Of Funds
Gross Block
Less: Revaluation Reserves

1,818.34
0.00
1,818.34
430.00
1,388.34
3,546.09
0.00
160.58
27.29

2,011.86
0.00
2,011.86
504.75
1,507.11
2,933.88
0.00
160.58
27.29

1,421.46
0.00
1,421.46
297.50
1,123.96
2,436.43
0.00
160.58
26.05

1,151.39
0.00
1,151.39
191.00
960.39
2,012.81
0.00
224.81
36.72

1,3

8,029.21
17.29
100.00
125.69

8,029.21
18.77
100.00
110.47

8,029.21
14.00
100.00
94.04

8,029.21
11.96
140.00
82.36

8,0

1,3
2
1,0
1,7

------------------- in Rs. Cr. ------------------Mar '14

Mar '13

Mar '12

Mar '11

12 mths

12 mths

12 mths

12 mths

12

39.07
39.07
0.00
0.00
286.49
325.56
0.00
0.00
0.00
325.56
Mar '14

39.07
39.07
0.00
0.00
217.47
256.54
0.00
0.00
0.00
256.54
Mar '13

39.07
39.07
0.00
0.00
147.79
186.86
0.00
0.00
0.00
186.86
Mar '12

39.07
39.07
0.00
0.00
102.82
141.89
0.00
0.00
0.00
141.89
Mar '11

1
M

12 mths

12 mths

12 mths

12 mths

12

67.67
0.00

63.58
0.00

62.74
0.00

61.14
0.00

Less: Accum. Depreciation


Net Block
Capital Work in Progress
Investments
Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deferred Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets
Miscellaneous Expenses
Total Assets
Contingent Liabilities
Book Value (Rs)

Profit & Loss account of


Zydus Wellness

Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure

14.54
53.13
0.00
145.65
4.63
0.23
163.93
168.79
5.73
0.00
174.52
0.00
20.12
27.62
47.74
126.78
0.00
325.56

12.20
51.38
0.00
95.73
6.74
0.46
146.15
153.35
5.08
0.00
158.43
0.00
21.26
27.74
49.00
109.43
0.00
256.54

9.97
52.77
0.08
47.71
6.04
0.36
127.17
133.57
84.53
0.00
218.10
0.00
31.33
100.47
131.80
86.30
0.00
186.86

7.94
53.20
0.31
39.70
17.49
1.17
7.80
26.46
9.65
78.65
114.76
0.00
46.46
19.62
66.08
48.68
0.00
141.89

3.26
83.32

1.58
65.66

2.71
47.82

2.83
36.31

1
1

------------------- in Rs. Cr. ------------------Mar '14

Mar '13

Mar '12

Mar '11

12 mths

12 mths

12 mths

12 mths

12

203.25
0.00
203.25
11.69
-2.45
212.49

213.01
0.00
213.01
13.89
0.07
226.97

254.77
1.18
253.59
8.64
-11.65
250.58

335.50
0.09
335.41
7.15
4.58
347.14

Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses
Selling and Admin Expenses
Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

Operating Profit
PBDIT
Interest
PBDT
Depreciation
Other Written Off
Profit Before Tax
Extra-ordinary items
PBT (Post Extra-ord Items)
Tax
Reported Net Profit
Total Value Addition
Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)
Shares in issue (lakhs)
Earning Per Share (Rs)
Equity Dividend (%)
Book Value (Rs)

56.77
1.30
12.95
0.00
0.00
48.44
0.00
119.46
Mar '14

64.91
1.26
11.96
0.00
0.00
47.14
0.00
125.27
Mar '13

81.43
1.16
11.29
0.07
67.90
7.71
0.00
169.56
Mar '12

124.90
1.06
15.64
0.24
105.97
7.72
0.00
255.53
Mar '11

2
M

12 mths

12 mths

12 mths

12 mths

12

81.34
93.03
0.00
93.03
2.43
0.00
90.60
0.00
90.60
-5.85
96.45
62.69
0.00
23.44
3.99

87.81
101.70
0.00
101.70
2.37
0.00
99.33
0.00
99.33
2.22
97.11
60.36
0.00
23.44
3.99

72.38
81.02
0.11
80.91
2.30
0.00
78.61
0.00
78.61
10.93
67.68
88.13
0.00
19.54
3.17

84.46
91.61
0.16
91.45
1.49
0.00
89.96
-0.24
89.72
30.24
59.48
130.63
0.00
15.63
2.54

390.72
24.69
60.00
83.32

390.72
24.85
60.00
65.66

390.72
17.32
50.00
47.82

390.72
15.22
40.00
36.31

Вам также может понравиться